Andry Tjia is an experienced quality assurance and quality control professional with a robust background in the biotechnology and pharmaceutical industries. Currently serving as the Associate Director of QA/QC at Denali Therapeutics since March 2023, Andry previously held various positions at Aimmune Therapeutics, including Principal QA and Quality Consultant in QA Operations from October 2019 to February 2023. Prior to this, Andry spent over 14 years at Genentech in roles ranging from Quality Engineer to Sr. Technical Manager. Andry also has experience as a Validation Engineer at Bayer from January 2002 to March 2005. Andry holds a Bachelor's degree in Chemical Engineering from the University of California, Berkeley.
This person is not in the org chart
This person is not in any offices